This Article Full Text Full Text (PDF) Submit a response Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Luo, H. Articles by Reidy, M. A. Search for Related Content PubMed PubMed Citation Articles by Luo, H. Articles by Reidy, M. A. Pubmed/NCBI databases Compound via MeSH Substance via MeSH Related Collections Cell signalling/signal transduction Smooth muscle proliferation and differentiation

(Arteriosclerosis, Thrombosis, and Vascular Biology. 2002;22:394.)
© 2002 American Heart Association, Inc.

Vascular Biology

Activation of Big Mitogen-Activated Protein Kinase-1 Regulates Smooth Muscle Cell Replication

Honglin Luo; Michael A. Reidy

From the Department of Pathology (M.A.R.), University of Washington, Seattle, and McDonald Research Laboratories/The iCAPTURE Centre, Department of Pathology and Laboratory Medicine (H.L.), St. Paul’s Hospital/Providence Health Care, University of British Columbia, Vancouver, Canada.

Correspondence to Michael A. Reidy, PhD, Department of Pathology, Box 357335, University of Washington, Seattle, WA 98195-7335. E-mail mar1{at}u.washington.edu

This study examined the activation of big mitogen-activated protein (MAP) kinase-1 (BMK1) in rat carotid smooth muscle cells (SMCs). Platelet-derived growth factor, fibroblast growth factor-2, sorbitol, and serum all increased the activation of BMK1 in rat carotid SMCs, whereas angiotensin II, phorbol esters, and tumor necrosis factor- had only slight effects. With the exception of tumor necrosis factor-, all these factors phosphorylated extracellular signal–regulated kinase (ERK)1/2. The MAPK kinase inhibitor (MEKI), U0126 (1 µmol/L), blocked ERK1/2 phosphorylation and at higher doses (5 µmol/L) blocked BMK1 phosphorylation. This inhibitor also blocked SMC DNA synthesis in a dose-dependent manner. When SMCs were transfected with an adenoviral construct expressing dominant mutant BMK1 and stimulated with fibroblast growth factor-2, a significantly smaller increase in cyclin D1 and cyclin A expression and in retinoblastoma factor phosphorylation was detected compared with the increase in cells transfected with an adenoviral construct expressing green fluorescent protein (GFP). SMC DNA synthesis was significantly blocked in the cells transfected with the dominant mutant BMK1. These data support the suggestion that BMK1 is important and necessary for mitogen-induced SMC proliferation.

Key Words: big mitogen-activated protein kinase 1 • smooth muscle cells • proliferation • dominant mutants • cyclins

This article has been cited by other articles:

				H. Zhang, D. Chalothorn, L. F. Jackson, D. C. Lee, and J. E. Faber Transactivation of Epidermal Growth Factor Receptor Mediates Catecholamine-Induced Growth of Vascular Smooth Muscle Circ. Res., November 12, 2004; 95(10): 989 - 997. [Abstract] [Full Text] [PDF]

				S. J. Cameron, J.-i. Abe, S. Malik, W. Che, and J. Yang Differential Role of MEK5{alpha} and MEK5{beta} in BMK1/ERK5 Activation J. Biol. Chem., January 9, 2004; 279(2): 1506 - 1512. [Abstract] [Full Text] [PDF]